On March 19, President Emmanuel Macron said “the Covid-19 crisis reminds us of the vital nature of scientific research and […]
Author: Ray El Boustany
Angiosafe – Covid-19
Diabetic patients are known to be at increased risk of infections. This is especially the case for viral infections and […]
Top Tips for Working from Home During the Coronavirus Pandemic
The global spread of COVID-19 is keeping people at home. Much of the world is on lockdown, and even in […]
CoviDIAB
CoviDIAB Personalized support during the coronavirus epidemic For diabetic patients confined during the COVID-19 epidemic, the AP-HP, in partnership with […]
Jean-Pierre Riveline publishes in JCEM
Type 2 diabetes is known to be one of the most complex chronic diseases. Well-defined diabetes risk factors include environmental […]
Louis Potier publishes in Diabetes Care
Lower-extremity amputation (LEA) is a major complication of diabetes and is associated with low quality of life and higher risk […]
Frédéric Fumeron publishes in Mol Metab
The present work was done in collaboration with the REGLYS team headed by Christophe Magnan at the Functional and Adaptative […]
Sylvain Girardot publishes in Diabetes Technol Ther
Continuous subcutaneous insulin infusion is one of the best ways to achieve optimal glucose control and to prevent chronic complications […]
IMMEDIAB retreat 2019
On the 19th of June, the entire Immediab team hopped on a train at Gare de Lyon, for the team’s […]
Frédéric Fumeron publishes in Diabetes & Metabolism
Type 2 diabetes is a multifactorial disease resulting from interactions between genetic susceptibility and environmental factors, including diet. Sphingolipids—in particular, […]
